Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Pharma
FDA accepts AZ's application for self-administered FluMist
The FDA has accepted AstraZeneca’s application for its FluMist to be self-administered. AZ expects a decision in next year's first quarter.
Kevin Dunleavy
Oct 24, 2023 12:12pm
Sanofi outlines €10B amibtion for its immunization future
Jun 29, 2023 11:46am
'The Top Line': Surprising multibillion-dollar medtech M&A deals
Mar 3, 2023 6:00am
Pfizer, Moderna and more look to combine COVID and flu markets
Jan 23, 2023 9:25am
Several generics makers report shortages of Roche's Tamiflu
Dec 21, 2022 9:03am
American Lung Association taps CSL Seqirus for flu vax campaign
Dec 6, 2022 9:00am